Status:
COMPLETED
Right Drug, Right Dose, Right Time - Using Genomic Data to Individualize Treatment
Lead Sponsor:
Mayo Clinic
Conditions:
Healthy Subjects
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is being done to better understand how genetic information related to drug dosing and use can affect medical care of patients. By doing this study, the investigators are developing and impr...
Detailed Description
The purpose of this research is to initiate a test of the concept that sequence information can be coupled to electronic medical records (EMRs) for use in healthcare.The focus of this study is on phar...
Eligibility Criteria
Inclusion
- Biobank participants who receive the majority of their care at Mayo Clinic based on EHR length and depth.
Exclusion
- Not in the Mayo Clinic Biobank. Do not receive the majority of their care at a Mayo Clinic site.
Key Trial Info
Start Date :
July 13 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
11098 Patients enrolled
Trial Details
Trial ID
NCT03803293
Start Date
July 13 2012
End Date
December 31 2019
Last Update
October 7 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.